Richard Schaefer took part in a clinical trial of psilocybin as a treatment for addiction. (Photo courtesy of Richard Schaefer) It was a day like any other when Richard Schaefer entered a Madison ...

Psilocybin, the active compound in hallucinogenic mushrooms, is edging into mainstream psychiatry in parts of Europe – with Switzerland already treating patients and the Czech Republic opening tightly ...

A top federal health official is again touting the therapeutic “promise” of psychedelics such as psilocybin and MDMA—though ...

New Hampshire lawmakers advanced a bipartisan bill to legalize the regulated use of psilocybin for medical purposes, while rejecting a separate measure on therapeutic access to the psychedelic. Weeks ...

Key points Magic mushrooms, or "shrooms," are increasingly popular among young adults and teens. Psilocybin, an illegal drug, is the psychoactive substance in hallucinogenic mushrooms. Emergency rooms ...

Harm caused by repeated concussions, especially in the context of sports, has gained attention in both research and the media. A new study has found that psilocybin, the psychedelic ingredient in ...

Earlier this week, outgoing Governor Murphy of New Jersey signed a bill creating a psilocybin therapy pilot program.

In a comparison of depression treatment trials, control group outcomes in trials of psilocybin were lower than those in trials of SSRIs and esketamine. This may suggest that psilocybin's ...

A3852 is for families who have lived in survival mode for years, carrying invisible wounds long after the uniform comes off.

An international collaboration led by Cornell researchers used a combination of psilocybin and the rabies virus to map how—and where—the psychedelic compound rewires the connections in the brain.

The Trump administration is set to weigh in on whether the hallucinogenic compound psilocybin should be moved into a less restrictive class of drugs under federal regulations. Regulation of psilocybin ...

Using psilocybin, the team at UW-Madison is developing groundbreaking new therapies tailor-made for people like Schaefer. Advertisements for the study, which focuses on opioid and methamphetamine ...